News & AnalysisBlackstone racks up $1.6bn for new life sciences fundBlackstone Life Sciences Yield will invest in late-stage product development.ByIris Dorbian21 April 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingEmerging ManagersFundraisingCommentary